Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
Endometrial Cancer
Type
Interventional
Phase
Phase 2
Design
Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Single-arm phase II study with safety run-in of adjuvant checkpoint blockade with radiation in women with Stage III-IVA, dMMR/MSI-H endometrial cancerMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT04774419
Collaborators
Tesaro, Inc.
Investigators
Principal Investigator: Ying Liu, MD, MPH Memorial Sloan Kettering Cancer Center